Flucytosine (Avera McKennan Hospital)
Welcome to the PulseAid listing for the Flucytosine drug offered from Avera McKennan Hospital. This Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antifungal [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Avera McKennan Hospital |
NON-PROPRIETARY NAME: | Flucytosine |
SUBSTANCE NAME: | FLUCYTOSINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antifungal [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-03-01 |
END MARKETING DATE: | 0000-00-00 |
Flucytosine HUMAN PRESCRIPTION DRUG Details:
Item Description | Flucytosine from Avera McKennan Hospital |
LABELER NAME: | Avera McKennan Hospital |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 250(mg/1) |
START MARKETING DATE: | 2015-03-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69189-0267_d42c679c-d76f-4cb1-a95e-8f6c8f847b2e |
PRODUCT NDC: | 69189-0267 |
APPLICATION NUMBER: | ANDA201566 |
Other FLUCYTOSINE Pharmaceutical Manufacturers / Labelers: